Mackenzie Financial’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
Mackenzie Financial's NVO Position: Q2 2026 in Review
Mackenzie Financial opened a new position in Novo Nordisk (NVO) in Q2 2026: 102,804 shares worth $4.93M. The stake represents ﹤0.01% of the portfolio and ranks #828 among its holdings. This is a return to the name: Mackenzie Financial previously reported a position in NVO as recently as Q3 2025.
Mackenzie Financial first reported a position in NVO in Q4 2016 and has held it in 13 quarters since. The position peaked at $16.1M in Q3 2025. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Mackenzie Financial held 102,804 shares of Novo Nordisk worth $4.93M as of Q2 2026.
- Novo Nordisk was a new Mackenzie Financial position in Q2 2026.
- Novo Nordisk made up ﹤0.01% of Mackenzie Financial's portfolio in Q2 2026, its #828 holding.
- Mackenzie Financial first reported a position in Novo Nordisk in Q4 2016 and has held it in 13 quarters since.
- Mackenzie Financial's Novo Nordisk position peaked at $16.1M in Q3 2025.
- 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.